Bill Giving FDA New Power Over Compounders Unveiled

Law360, New York (April 26, 2013, 2:42 PM EDT) -- Senate health committee leaders on Friday announced legislation that would give the U.S. Food and Drug Administration new authority to directly regulate certain compounding pharmacies, which would be defined as “compounding manufacturers” and no longer licensed as pharmacies.

The draft bill is a response to last year's deadly, widespread fungal meningitis outbreak, which was traced to contaminated drugs made by New England Compounding Center in Massachusetts. More than 700 people were affected and 53 people killed.

Compounding pharmacies traditionally make custom-order drugs for patients with special...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.